IONIS PHARMACEUTICALS INC — Director's Dealing 2018

Feb 5, 2018

SEC Form 4/A — Form 4/A

Issuer: IONIS PHARMACEUTICALS INC (IONS)
CIK: 0000874015
Period of Report: 2018-02-03

Reporting Person: LOSCALZO JOSEPH (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-03	Common Stock	M	937	—	Acquired	7752	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-03	Restricted Stock Units	$	M	937	Disposed		Common Stock (937)	Direct

Footnotes

F1: Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on February 3, 2014.

F2: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis commn stock, or its equivalent cash value.

F3: Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis ommon stock or cash as may be determined by the Company.